Journal Management System
ScopeMed is an
Online Journal/Article Management system
that can enable all of the operations of
the editorial functions of a journal.
Home  |   Add your Journal  |   Features  |   Job Opportunities  |   Journal List
Author Login | Reviewer Login | Editor Login
Search  

Medical Archives
Periodical of AVICENA, d.o.o., Sarajevo
Journal Home Page
ISSN: 0350-199X (Print)
ISSN: 1986-5961 (Online)
Language: [ English ]  
News / Announcements

  » Volume 68, Issue 1
      pp. 4-70

 

Open Access

Review Article



Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach

Azra Husic-Selimovic, Zora Vukobrat-Bijedic, Milenko Bevanda, Rusmir Mesihovic, Enver Zerem, Sead Ahmetagic, Stevan Trbojevic, Antonija Verhaz, Zdravka Kezic, Muharem Zildzic, Janja Bojanic, Jasminka Petrovic, Vildana Stojic, Merdina Ferhatovic, Nevzeta Ibrahimpasic, Visnja Mrdjen, Nera Zivlak, Tatjana Barac, Helien Bebek-Ivankovic, Lejla Calkic, Maja Karin, Aleksandar Dobrovoljski, Romana Rajic, Milan Skrbic, Nenad Babic, Daniela Bevanda-Glibo.

A B S T R A C TR E F E R E N C E SCited by (1) 

Abstract
Association of Gastroenterologists and Hepatologists of Bosnia and Herzegovina based on the experiences of domestic and foreign centers operating in the field of hepatology and accepted guidelines of the European and the U.S. Association for Liver Diseases adopted the consensus for the diagnosis and treatment of chronic viral hepatitis B and C. The guidelines are intended for specialists in gastroenterology and hepatology, and infectious diseases physicians working in primary health care and family medicine, but also other physicians who are confronted with this disease in their practice, with the aim of facilitating and shortening the diagnostic and treatment protocols of patients with chronic viral hepatitis B and C. This ensures faster, more efficient, more rational and cost-effective care of patients with hepatitis, with an emphasis on stopping the deterioration of liver disease to liver cirrhosis and eventually hepatocellular carcinoma.

Key words: Chronic hepatitis B and C, treatment, guidelines..


ARTICLE TOOLS
Abstract
PDF Fulltext
Email this Article
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Azra Husic-Selimovic
Articles by Zora Vukobrat-Bijedic
Articles by Milenko Bevanda
Articles by Rusmir Mesihovic
Articles by Enver Zerem
Articles by Sead Ahmetagic
Articles by Stevan Trbojevic
Articles by Antonija Verhaz
Articles by Zdravka Kezic
Articles by Muharem Zildzic
Articles by Janja Bojanic
Articles by Jasminka Petrovic
Articles by Vildana Stojic
Articles by Merdina Ferhatovic
Articles by Nevzeta Ibrahimpasic
Articles by Visnja Mrdjen
Articles by Nera Zivlak
Articles by Tatjana Barac
Articles by Helien Bebek-Ivankovic
Articles by Lejla Calkic
Articles by Maja Karin
Articles by Aleksandar Dobrovoljski
Articles by Romana Rajic
Articles by Milan Skrbic
Articles by Nenad Babic
Articles by Daniela Bevanda-Glibo
on IndexScholar Fulltext
on Google
on Google Scholar
Article Statistics
 Viewed: 990
Downloaded: 242
(Last 7 Days: 3)
Cited: 1
Emailed: 1

REFERENCES
1. Sorrell MF. et al. Ann Intern Med. 2009; 150: 104-110.
[Pubmed]   

2. Lin SY. et al. Hepatology. 2007; 46: 1034-1040.
[
DOI via Crossref]    [Pubmed]   

3. CDC. MMWR. 2007; 56: 446-448.

4. Centers for Disease Control and Prevention. CDC Health Information 2010.

5. CM, et al. MMWR Recomm Rep. 2008; 57(RR-8); 1-20.

6. Keeffe EB. et al. Clin Gastroenterol Hepatol. 2008; 6: 1315-1341.
[
DOI via Crossref]    [Pubmed]   

7. Hadziyannis SJ.et al. Semin Liver Dis. 2006; 26: 130-141.
[
DOI via Crossref]    [Pubmed]   

8. EASL. J Hepatol. 2009; 50: 227-242.
[
DOI via Crossref]    [Pubmed]   

9. Liaw YF. et al. Hepatol Int. 2008; 3: 263-283.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

10. EASL HBV Guidelines. J Hepatol. 2009; 50: 227-242.
[
DOI via Crossref]    [Pubmed]   

11. Lok ASF, McMahon BJ. Hepatology. 2009; 50: 661-662.
[
DOI via Crossref]    [Pubmed]   

12. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J. et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med. 1990; 323: 295–301.
[
DOI via Crossref]    [Pubmed]   

13. Wong DK, Cheung AM, O’Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A metaanalysis. Ann Intern Med. 1993; 119: 312-323.
[
Pubmed]   

14. Zoulim F, Perrillo R. Hepatitis B: reflections on the current approach to antiviral therapy. J Hepatol. 2008; 48 (Suppl. 1): S2-S19.
[
DOI via Crossref]    [Pubmed]   

15. Bonino F, Marcellin P, Lau GK, Hadziyannis S, Jin R, Piratvisuth T. et al. Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B. Gut. 2007; 56: 699-705.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

16. Fried MW, Piratvisuth T, Lau GKK, Marcellin P, Chow WC, Cooksley G. et al. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HbeAg positive chronic hepatitis B. Hepatology. 2008; 47: 428-434.
[
DOI via Crossref]    [Pubmed]   

17. Perrillo RP, Lai CL, Liaw YF, Dienstag JL, Schiff ER, Schalm SW. et al. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology. 2002; 36: 186-194.
[
DOI via Crossref]    [Pubmed]   

18. Terrault N, Viral Hepatitis. Clinical Care Options Hepatitis, 2009.

19. Buster EH, Hansen BE, Buti M, Delwaide J, Niederau C, Michielsen PP, et al. Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis. Hepatology. 2007; 46: 388-394.
[
DOI via Crossref]    [Pubmed]   

20. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Hematol. 2007; 136: 699-712.
[
DOI via Crossref]    [Pubmed]   

21. Mindikoglu AL, Regev A, Schiff ER. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastroenterol Hepatol. 2006; 4: 1076-1081.
[
DOI via Crossref]    [Pubmed]   

22. Hui CK, Cheung WWW, Zhang HY, Au WY, Yueng YH, Leung AYH. et al. Rituximab increases the risk of de novo hepatitis B infection in hepatitis B surface antigen negative patients undergoing cytotoxic chemotherapy. J Gastroenterol Hepatol. 2006; 21: A73–A74.

23. Rostaing L, Henry S, Cisterne JM, Duffaut M, Icart J, Durand D. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation. Transplantation. 1997; 64: 1624-1627.
[
DOI via Crossref]    [Pubmed]   

24. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2003; 10: 294-297.
[
DOI via Crossref]    [Pubmed]   

25. Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet. 1996; 348: 1212-1215.
[
DOI via Crossref]   

26. Samuel D. Management of hepatitis B in liver transplantation patients. Semin Liver Dis. 2004; 24 (Suppl. 1): 55-62.
[
DOI via Crossref]    [Pubmed]   

27. Schiff E, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, et al. Adefovir dipivoxil for wait-listed and postliver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transplant. 2007; 13: 349-360.
[
DOI via Crossref]    [Pubmed]   

This Article Cited By the following articles

Use of ALLGIO Probe Assays for Detection of HBV Resistance to Adefovir in Patients with Chronic Hepatitis B, Kerman, Iran
Asian Pacific Journal of Cancer Prevention 2012; 13(11): 5463.

1
 

How to Cite this Article
Pubmed Style

Husic-Selimovic A, Vukobrat-Bijedic Z, Bevanda M, Mesihovic R, Zerem E, Ahmetagic S, Trbojevic S, Verhaz A, Kezic Z, Zildzic M, Bojanic J, Petrovic J, Stojic V, Ferhatovic M, Ibrahimpasic N, Mrdjen V, Zivlak N, Barac T, Bebek-Ivankovic H, Calkic L, Karin M, Dobrovoljski A, Rajic R, Skrbic M, Babic N, Bevanda-Glibo D. Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach. Med Arh. 2012; 66(Suplement 1): 56-68. doi:10.5455/medarh.2012.66.s56-s68



Web Style

Husic-Selimovic A, Vukobrat-Bijedic Z, Bevanda M, Mesihovic R, Zerem E, Ahmetagic S, Trbojevic S, Verhaz A, Kezic Z, Zildzic M, Bojanic J, Petrovic J, Stojic V, Ferhatovic M, Ibrahimpasic N, Mrdjen V, Zivlak N, Barac T, Bebek-Ivankovic H, Calkic L, Karin M, Dobrovoljski A, Rajic R, Skrbic M, Babic N, Bevanda-Glibo D. Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach. www.scopemed.org/?mno=22480 [Access: April 20, 2014]. doi:10.5455/medarh.2012.66.s56-s68



AMA (American Medical Association) Style

Husic-Selimovic A, Vukobrat-Bijedic Z, Bevanda M, Mesihovic R, Zerem E, Ahmetagic S, Trbojevic S, Verhaz A, Kezic Z, Zildzic M, Bojanic J, Petrovic J, Stojic V, Ferhatovic M, Ibrahimpasic N, Mrdjen V, Zivlak N, Barac T, Bebek-Ivankovic H, Calkic L, Karin M, Dobrovoljski A, Rajic R, Skrbic M, Babic N, Bevanda-Glibo D. Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach. Med Arh. 2012; 66(Suplement 1): 56-68. doi:10.5455/medarh.2012.66.s56-s68



Vancouver/ICMJE Style

Husic-Selimovic A, Vukobrat-Bijedic Z, Bevanda M, Mesihovic R, Zerem E, Ahmetagic S, Trbojevic S, Verhaz A, Kezic Z, Zildzic M, Bojanic J, Petrovic J, Stojic V, Ferhatovic M, Ibrahimpasic N, Mrdjen V, Zivlak N, Barac T, Bebek-Ivankovic H, Calkic L, Karin M, Dobrovoljski A, Rajic R, Skrbic M, Babic N, Bevanda-Glibo D. Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach. Med Arh. (2012), [cited April 20, 2014]; 66(Suplement 1): 56-68. doi:10.5455/medarh.2012.66.s56-s68



Harvard Style

Husic-Selimovic, A., Vukobrat-Bijedic, Z., Bevanda, M., Mesihovic, R., Zerem, E., Ahmetagic, S., Trbojevic, S., Verhaz, A., Kezic, Z., Zildzic, M., Bojanic, J., Petrovic, J., Stojic, V., Ferhatovic, M., Ibrahimpasic, N., Mrdjen, V., Zivlak, N., Barac, T., Bebek-Ivankovic, H., Calkic, L., Karin, M., Dobrovoljski, A., Rajic, R., Skrbic, M., Babic, N. & Bevanda-Glibo, D. (2012) Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach. Med Arh, 66 (Suplement 1), 56-68. doi:10.5455/medarh.2012.66.s56-s68



Turabian Style

Husic-Selimovic, Azra, Zora Vukobrat-Bijedic, Milenko Bevanda, Rusmir Mesihovic, Enver Zerem, Sead Ahmetagic, Stevan Trbojevic, Antonija Verhaz, Zdravka Kezic, Muharem Zildzic, Janja Bojanic, Jasminka Petrovic, Vildana Stojic, Merdina Ferhatovic, Nevzeta Ibrahimpasic, Visnja Mrdjen, Nera Zivlak, Tatjana Barac, Helien Bebek-Ivankovic, Lejla Calkic, Maja Karin, Aleksandar Dobrovoljski, Romana Rajic, Milan Skrbic, Nenad Babic, and Daniela Bevanda-Glibo. 2012. Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach. Medical Archives, 66 (Suplement 1), 56-68. doi:10.5455/medarh.2012.66.s56-s68



Chicago Style

Husic-Selimovic, Azra, Zora Vukobrat-Bijedic, Milenko Bevanda, Rusmir Mesihovic, Enver Zerem, Sead Ahmetagic, Stevan Trbojevic, Antonija Verhaz, Zdravka Kezic, Muharem Zildzic, Janja Bojanic, Jasminka Petrovic, Vildana Stojic, Merdina Ferhatovic, Nevzeta Ibrahimpasic, Visnja Mrdjen, Nera Zivlak, Tatjana Barac, Helien Bebek-Ivankovic, Lejla Calkic, Maja Karin, Aleksandar Dobrovoljski, Romana Rajic, Milan Skrbic, Nenad Babic, and Daniela Bevanda-Glibo. "Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach." Medical Archives 66 (2012), 56-68. doi:10.5455/medarh.2012.66.s56-s68



MLA (The Modern Language Association) Style

Husic-Selimovic, Azra, Zora Vukobrat-Bijedic, Milenko Bevanda, Rusmir Mesihovic, Enver Zerem, Sead Ahmetagic, Stevan Trbojevic, Antonija Verhaz, Zdravka Kezic, Muharem Zildzic, Janja Bojanic, Jasminka Petrovic, Vildana Stojic, Merdina Ferhatovic, Nevzeta Ibrahimpasic, Visnja Mrdjen, Nera Zivlak, Tatjana Barac, Helien Bebek-Ivankovic, Lejla Calkic, Maja Karin, Aleksandar Dobrovoljski, Romana Rajic, Milan Skrbic, Nenad Babic, and Daniela Bevanda-Glibo. "Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach." Medical Archives 66.Suplement 1 (2012), 56-68. Print. doi:10.5455/medarh.2012.66.s56-s68



APA (American Psychological Association) Style

Husic-Selimovic, A., Vukobrat-Bijedic, Z., Bevanda, M., Mesihovic, R., Zerem, E., Ahmetagic, S., Trbojevic, S., Verhaz, A., Kezic, Z., Zildzic, M., Bojanic, J., Petrovic, J., Stojic, V., Ferhatovic, M., Ibrahimpasic, N., Mrdjen, V., Zivlak, N., Barac, T., Bebek-Ivankovic, H., Calkic, L., Karin, M., Dobrovoljski, A., Rajic, R., Skrbic, M., Babic, N. & Bevanda-Glibo, D. (2012) Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach. Medical Archives, 66 (Suplement 1), 56-68. doi:10.5455/medarh.2012.66.s56-s68







Total Download: 142.864
(for Medical Archives)
Total Submission during last 24 hours: 159


» For Authors




Become Reviewer


» Login Area




Follow ScopeMed on Twitter

ScopeMed Home | About ScopeMed | Contact Us | Terms & Conditions | Privacy Policy
The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of SAGEYA Publishing for Scientific Publications. Copyright © ScopeMed® International Medical Journal Management and Indexing System.